Richard J. Rubino
2013
In 2013, Richard J. Rubino earned a total compensation of $2M as Chief Financial Officer at Aerie Pharmaceuticals, a 161% increase compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $558,639 |
| Salary | $303,849 |
| Stock Awards | $1,075,999 |
| Total | $2,013,487 |
Rubino received $1.1M in stock awards, accounting for 53% of the total pay in 2013.
Rubino also received $75K in bonus, $558.6K in option awards and $303.8K in salary.
Rankings
In 2013, Richard J. Rubino's compensation ranked 3,873rd out of 12,286 executives tracked by ExecPay. In other words, Rubino earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,873 out of 12,286 | 69th |
Division Manufacturing | 1,311 out of 4,612 | 72nd |
Major group Chemicals And Allied Products | 357 out of 1,466 | 76th |
Industry group Drugs | 250 out of 1,160 | 78th |
Industry Biological Products, Except Diagnostic Substances | 36 out of 200 | 82nd |
Source: SEC filing on February 27, 2015.
Rubino's colleagues
We found four more compensation records of executives who worked with Richard J. Rubino at Aerie Pharmaceuticals in 2013.
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019